AstraZeneca stops sponsoring doctors' foreign trips amid scrutiny

05/30/2011 | Reuters

AstraZeneca decided to stop paying clinicians to attend scientific meetings overseas amid regulatory scrutiny of drugmakers' financial relationship with the medical community. AstraZeneca will focus instead on "local educational opportunities," CEO David Brennan said. The drug industry reportedly paid the government $15 billion in fines during the past five years for violation of federal law.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care